{
    "Trade/Device Name(s)": [
        "ACCU-CHEK Aviva Plus Blood Glucose Monitoring System",
        "ACCU-CHEK Aviva Meter",
        "ACCU-CHEK Aviva Plus Test Strip",
        "ACCU-CHEK Aviva Control Solutions"
    ],
    "Submitter Information": "Roche Diagnostics Corporation",
    "510(k) Number": "K101299",
    "Predicate Device Reference 510(k) Number(s)": [
        "K060620",
        "K043474"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "JJX"
    ],
    "Summary Letter Date": "September 16, 2011",
    "Summary Letter Received Date": "September 19, 2011",
    "Submission Date": "August 03, 2011",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ACCU-CHEK Aviva Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical detection"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for ACCU-CHEK Aviva Plus Blood Glucose Monitoring System for self-testing of glucose in capillary whole blood using electrochemical detection.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from fingertips, forearm, upper arm, or palm for self-testing by people with diabetes at home to monitor diabetes control; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}